This year’s Conference on Retroviruses and Opportunistic Infections (CROI) features several sessions discussing prevention ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...

Funding Gaps: There is a funding gap of USD 1.9 million for procuring 30,000 three-month ART courses needed to sustain treatment through 2025. Ukraine’s Public Health Centre may request a state budget ...

The major backer of the lenacapavir roll-out is assuring nervous researchers that they will keep their part of funding promises. It's a good economic investment, says the Fund's Peter Sands, into a ...

Already, significant harm has been done to inhibit progress combating HIV/AIDS, and the next four years could return us to ...

Gilead Sciences sets aside $200 million for a potential settlement over its HIV drug promotional speaker program amid federal investigation.

OLYMPIA, Wash.–A Washington bill that would ensure the Medicaid program in the state continues covering HIV antiviral drugs ...